2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -98.65%1-Year Change
- Pharmaceutical RetailersIndustry
RIDGETECH (RDGT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 61
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
What's Going On With Ridgetech Shares On Tuesday?
Ridgetech (NASDAQ:RDGT) shares declined 23.74% during Tuesday's premarket trading to $2.73. The stock decline occurs amid broader market weakness, with the S&P 500 and Nasdaq both edging lower. The company is pursuing a 2026 dual-engine growth strategy focused on supply chain integration and expanding its digital platform, aiming to increase its customer base to over 300,000. Technical analysis shows the stock is overbought with an RSI of 79.94, suggesting potential pullbacks despite bullish MACD momentum. Ridgetech is scheduled to report earnings on April 6, 2026.
03/24/2026, 9:33 AM • Benzinga
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.
Key Executives
- Ming Zhao
- Yan Liu
- Steve Liu
Current Ownership Distribution
- Other260 (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)